Central nervous system cancers, version 2.2014 Journal Article


Authors: Nabors, L. B.; Portnow, J.; Ammirati, M.; Brem, H.; Brown, P.; Butowski, N.; Chamberlain, M. C.; Deangelis, L. M.; Fenstermaker, R. A.; Friedman, A.; Gilbert, M. R.; Hattangadi-Gluth, J.; Hesser, D.; Holdhoff, M.; Junck, L.; Lawson, R.; Loeffler, J. S.; Moots, P. L.; Mrugala, M. M.; Newton, H. B.; Raizer, J. J.; Recht, L.; Shonka, N.; Shrieve, D. C.; Sills, A. K. Jr; Swinnen, L. J.; Tran, D.; Tran, N.; Vrionis, F. D.; Wen, P. Y.; McMillian, N. R.; Ho, M.
Article Title: Central nervous system cancers, version 2.2014
Abstract: The NCCN Guidelines for Central Nervous System Cancers provide multidisciplinary recommendations for the clinical management of patients with cancers of the central nervous system. These NCCN Guidelines Insights highlight recent updates regarding the management of metastatic brain tumors using radiation therapy. Use of stereotactic radiosurgery (SRS) is no longer limited to patients with 3 or fewer lesions, because data suggest that total disease burden, rather than number of lesions, is predictive of survival benefits associated with the technique. SRS is increasingly becoming an integral part of management of patients with controlled, low-volume brain metastases.
Keywords: cancer survival; cancer radiotherapy; brain tumor; practice guideline; central nervous system tumor; patient care; brain metastasis; continuing education; stereotactic radiosurgery; predictive value; human; article
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 12
Issue: 11
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2014-11-01
Start Page: 1517
End Page: 1523
Language: English
PROVIDER: scopus
PUBMED: 25361798
PMCID: PMC4337873
DOI/URL:
Notes: Export Date: 1 December 2014 -- Source: Scopus
Citation Impact
MSK Authors